PLoS ONE

PLoS One. 13(11): e0207870

Testosterone is not associated with traits of optimism or pessimism: Observational evidence from the prospective DETECT study

Hanna Kische, Formal analysis, Writing – original draft¹, Jürgen Hoyer, Writing – review & editing², Lars Pieper, Conceptualization, Methodology¹, John Venz, Data curation¹, Jens Klotsche, Conceptualization, Writing – review & editing³, Winfried März, Writing – review & editing⁴, Uwe Koch-Gromus, Writing – review & editing⁵, David Pittrow, Writing – review & editing⁶, Hendrik Lehnert, Writing – review & editing⁷, Sigmund Silber, Writing – review & editing⁸, Günter K. Stalla, Methodology, Validation, Writing – review & editing⁹, Andreas M. Zeiher, Writing – review & editing¹⁰, Hans-Ulrich Wittchen, Investigation, Methodology, Resources, Writing – review & editing¹¹, http://orcid.org/0000-0002-8332-5016Robin Haring, Conceptualization, Supervision, Writing – review & editing¹²¹³*

Peter Karl Jonason, Editor

1. Behavioral Epidemiology, Institute of Clinical Psychology and Psychotherapy, Technical University of Dresden, Dresden, Germany

2. Institute of Clinical Psychology and Psychotherapy, Technical University of Dresden, Dresden, Germany

3. German Rheumatism Research Centre Berlin, Berlin, Germany

4. Medical Clinic V, Medical Faculty Mannheim at Heidelberg University, Heidelberg, Germany

5. Department of Medical Psychology, University Medical Center Eppendorf, Hamburg, Germany

6. Institute of Clinical Pharmacology, Medical Faculty, Technical University of Dresden, Dresden, Germany

7. Department of Medicine I, University of Schleswig-Holstein, Lübeck, Germany

8. Cardiology Practice and Hospital, Munich, Germany

9. Max Planck Institute of Psychiatry, Munich, Germany

10. Department of Medicine III Cardiology, Goethe University Frankfurt, Frankfurt, Germany

11. Institute of Clinical Psychology and Psychotherapy, Technical University of Dresden, Dresden, Germany

12. European University of Applied Sciences, Faculty of Applied Public Health, Rostock, Germany

13. School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia

Western Sydney University, AUSTRALIA

Competing Interests: The authors have declared that no competing interests exist.

* E-mail: robin.haring@monash.edu

© 2018 Kische et al

DOI: 10.1371/journal.pone.0207870

Published online: 29 November 2018

Abstract

Background

Previous experimental research on testosterone (T) and psychological traits is inconclusive. Thus, we performed the first large-scale observational study of the association between T and dispositional optimism / pessimism.

Methods

We used prospective data from 6,493 primary-care patients (3,840 women) of the DETECT study (Diabetes Cardiovascular Risk-Evaluation: Targets and Essential Data for Commitment of Treatment), including repeated immunoassay-based measurement of serum T and optimism / pessimism assessed by the revised Life-Orientation Test (LOT-R). Cross-sectional and longitudinal associations of baseline T and one-year change in T with optimism and pessimism were investigated using age- and multivariable-adjusted regression models.

Results

Cross-sectional analyses showed no association of T with optimism or pessimism in both sexes. Longitudinal analyses also showed no association of baseline T with optimism or pessimism at four-year follow-up. Multivariable analyses of total LOT-R score yielded similarly non-significant results (β-coefficient per unit change in T for men: -0.01 (95% CI: -0.24–0.22), women: 0.08 (-0.03–0.20)). Furthermore, change in T was not related to optimism or pessimism at four-year follow-up.

Conclusions

The present observational study of a large-scale prospective sample showed no association of T with optimism or pessimism. Integrating further experimental and interventional evidence from alternative methodological approaches would strengthen this conclusion and establish stronger evidence about the potential hormonal basis of psychological traits.

Introduction

From its first use in the treatment of depression in 1948 [1], testosterone (T) has a long clinical history in the application for psychological disorders. Between 1950 and 2016, a recent systematic review identified 45 randomized controlled trials (RCT) investigating the effect of T treatment on personality, well-being or mood, but without any consistent effect on psychological outcomes [2].

The empirical evidence for a link between T and psychological traits, such as optimism and pessimism, is only weak. Initial support for a potential hormonal basis of psychological traits relies on findings from two different strands of literature. First, research on prenatal T provides tentative evidence that traits are—at least partially—biologically determined [3]. Secondly, experimental research in economic decision-making suggests a potential link of T with risk-taking, overconfidence and optimism [4]. However, the exact association between T and psychological traits is still elusive [5]. Therefore, we investigated the association of T with optimism and pessimism using cross-sectional and longitudinal data from a large patient-based sample of men and women.

Methods

Study population

The Diabetes Cardiovascular Risk-Evaluation: Targets and Essential Data for Commitment of Treatment (DETECT) study is a prospective primary-care study in Germany. Details of the study design, recruitment, and procedures were previously published [6]. In brief, of 55,518 eligible patients at baseline, a random subsample of 7,519 patients was recruited in 851 primary-care settings. Of these, 6,826 patients (2,782 men and 4,044 women) participated in one-year and/or four-year follow-up assessments between September and December 2004 and 2007, respectively. The follow-up response rate was 90.8%. All patients gave written informed consent and the study was approved by the ethics committee of the Technical University of Dresden. We excluded patients due to missing T data (N = 896), baseline age above 86 years (N = 30), and use of anti-androgens (N = 100). None of the women were pregnant. The final study comprised of 2,653 men and 3,840 women.

Measurements

Socio-demographics and medical history were assessed by primary-care physicians using standardized interviews and medical records. Blood pressure, height, weight, and waist circumference were measured according to standardized instructions. For smoking, alcohol consumption, and physical activity we used the following categorized variables: Smoking was categorized into current smokers and non-smokers. Alcohol consumption was categorized in self-reported sobriety, infrequent, occasional or daily alcohol consumption. Participants who participated in physical activity during summer or winter for at least two hour a week were classified as being physically active.

The revised version of the 10 item Life Orientation Test (LOT-R) was used to define optimism as a sub-score including items 1, 4, and 10 and pessimism including items 3, 7, and 9, as previously described [7]. Repeated measurements of baseline and one-year follow-up T concentrations based on blood samples taken between 8.00 and 10.00 a.m. and were performed using an electrochemiluminescence immunoassay (Modular analytics, Roche Diagnostics, Mannheim, Germany) with an intra- and interassay coefficient of variation of 2.7% and 5.6%, respectively. Full laboratory procedures were published previously [8].

Statistical analyses

First, cross-sectional and longitudinal associations of continuous T with optimism, pessimism, and total LOT-R score were analyzed using age- and multivariable-adjusted linear regression models, with effects reported as β-coefficients and their 95% confidence interval (CI). Second, T change was defined as absolute difference between baseline and one-year follow-up T, with associations between T change and LOT-R investigated by linear regression models. Normality of residuals was tested using QQ plots and normality of outcome variables was inspected visually. Multivariable models were adjusted for age, waist-circumference, smoking habits, physical activity, alcohol consumption, and blood pressure. To address potential attrition bias, we included inverse probability weights into longitudinal multivariable analyses. All analyses were performed with robust standard errors and p-values < 0.05 as threshold for statistical significance. Statistical analyses were performed with Stata 15.0 (Stata Corp., College Station, TX, USA).

Results

Sex-specific baseline characteristics of the study population are presented in Table 1. Cross-sectional analyses showed no association of T with optimism, pessimism or total LOT-R score among men and women (Table 2). Assessing a continuum of T concentrations and LOT-R scores, we observed no graded slope between T and optimism or pessimism (Fig 1). Longitudinal analyses of optimism, pessimism, and total LOT-R score yielded similarly non-significant results (multivariable-adjusted β-coefficients per one unit T change for LOT-R: men, -0.01 (95% CI: -0.24–0.22); women, 0.08 (-0.03–0.20)). Finally, one-year change in T was not related to optimism, pessimism or total LOT-R at four-year follow-up. None of the performed sensitivity analyses changed the revealed findings.

Fig 1View larger versionFig 1. Optimism and pessimism by baseline testosterone among men.Linear regression for baseline optimism (green) and pessimism (blue) by baseline total testosterone concentrations. The green and blue lines represent the fitted regression line and the grey areas the 95% confidence intervals.

See full table Table 1. Sex-specific baseline characteristics of the study population.

See full table Table 2. Sex-specific associations of total testosterone with optimism, pessimism, and total LOT-R.

Discussion

To the best of our knowledge, this is the first observational study to investigate the association of T with optimism and pessimism in a large-scale sample of men and women. Taken together, cross-sectional and longitudinal analyses showed no association of T with dispositional optimism and pessimism, assessed by the LOT-R.

The tentative role of T as hormonal correlate of psychological traits stems from research in prenatal T exposure and economic decision-making. Using the right hand 2D:4D digit ratio (length of the index finger to the length of the ring finger) as putative marker for relative prenatal T exposure, the 2D:4D ratio has been shown to correlate with traits such as altruism [9], cooperation [10], and cognitive reflection [11]. Another line of research in economic decision-making suggests that T is linked to optimism and risk-taking [4], trust, and self-confidence [12]. But given their small scale, strongly selected samples, and narrow focus, the results of these studies are of low generalizability and do not allow for definite conclusions about a potential link between T and personality traits.

The absent association of endogenous T with dispositional optimism and pessimism in the present study provides a rationale for the lack of interventional evidence reporting no conclusive effect of exogenous T on personality, psychological well-being or mood in clinical trials [2]. Although men under T treatment occasionally show slightly better mood and lower severity of depressive symptoms, as reported by the long-awaited T-trials [13], the statistical significance of these findings does not compensate for their small effect size and unknown clinical significance. Also the suggested dose-response relationship between T and several domains of psychological well-being did not stand up to closer scrutiny. Exemplarily, a RCT among 44 healthy older men receiving five graded T doses over 20 weeks showed not effect on two measures of mood, including Hamilton's Depression Inventory and Young's Mania Scale [14].

Alternatively, change in T itself has been suggested as a relevant predictor of adverse health outcomes [15], risk taking behavior [16], and depressive symptoms [8]. However, on the level of psychological traits, the absence of an association of T change with optimism and pessimism in the present study is in line with synthesized evidence of a systematic review including 27 observational studies among healthy male adolescents, experiencing marked T changes during puberty, reporting no association of T change with behavior [17].

Although our findings agree with previous data showing low correlations between optimism and multiple laboratory parameters in the DETECT study, it is important to mention differences in the analyses of the LOT-R. While some studies investigated optimism and pessimism as two independent constructs [18], others assessed optimism as a continuous measure [19]. To address this methodological heterogeneity, we analyzed both: two-dimensional optimism and pessimism variables, as well as a continuous LOT-R score as one-dimensional trait. However, both analytical strategies yielded non-significant results.

The interpretation of the observational evidence presented here warrants consideration of the following strengths and potential limitations. Strengths of our study include the large sample size, repeated follow-up measures, and the comparative assessment of baseline T vs. T change in men as well as in women. Limitations may arise from the questionnaire-based assessment of LOT-R, relying on subjective and potentially inaccurate patient responses. Furthermore, our study is limited by the lack of data regarding additional sex hormones and alternative measures of the optimism-pessimism continuum, such as the Unrealistic Optimism Scale, the Hope Scale or the Optimism-Pessimism Scale [20].

In summary, the observational data reported here shows no association of T with optimism, pessimism or total LOT-R score, suggesting further research to elucidate potential direct and indirect associations between individual hormonal status and psychological traits.

Acknowledgments

DETECT (Diabetes Cardiovascular Risk-Evaluation: Targets and Essential Data for Commitment of Treatment) is a cross-sectional and prospective-longitudinal, nationwide clinical epidemiological study. DETECT is supported by an unrestricted educational grant of Pfizer GmbH, Karlsruhe, Germany. Members of the DETECT-Study group include: Principal investigator: Professor Dr. H.-U. Wittchen; Staff members: Dr. L. Pieper, Dr. J. Klotsche, Dr. T. Eichler, Dr. H. Glaesmer, E. Katze. Steering Committee: Professor Dr. H. Lehnert (Lübeck), Professor Dr. G. K. Stalla (München), Professor Dr. A. M. Zeiher (Frankfurt); Advisory Board: Professor Dr. W. März (Heidelberg/Graz), Professor Dr. S. Silber (München), Professor Dr. Dr. U. Koch-Gromus (Hamburg), Professor Dr. D. Pittrow (München/Dresden), Professor Dr. M. Wehling (Mannheim), Dr. D. Leistner (Frankfurt), Professor Dr. H. J. Schneider (München), Dr. C. Sievers (München). The current data analysis was conducted within BMBF Grants 01ER1303 & 01ER1703.

Articles from PLoS ONE are provided here courtesy of Public Library of Science

PMC Copyright Notice

The articles available from the PMC site are protected by copyright, even though access is free. Copyright is held by the respective authors or publishers who provide these articles to PMC. Users of PMC are responsible for complying with the terms and conditions defined by the copyright holder.

Users should assume that standard copyright protection applies to articles in PMC, unless an article contains an explicit license statement that gives a user additional reuse or redistribution rights. PMC does not allow automated/bulk downloading of articles that have standard copyright protection.

See the copyright notice on the PMC site, https://www.ncbi.nlm.nih.gov/pmc/about/copyright/, for further details and specific exceptions.

References

Altschule MD, Tillotson KJ. The use of testosterone in the treatment of depressions. The New England journal of medicine. 1948;239(27):1036–8. Epub 1948/12/30. 10.1056/NEJM194812302392704 .18103557

Huo S, Scialli AR, McGarvey S, Hill E, Tugertimur B, Hogenmiller A, et al Treatment of Men for "Low Testosterone": A Systematic Review. PloS one. 2016;11(9):e0162480 Epub 2016/09/23. 10.1371/journal.pone.0162480 ; PubMed Central PMCID: PMCPMC5031462.27655114

Millet K, Buehler F. A Context Dependent Interpretation of Inconsistencies in 2D:4D Findings: The Moderating Role of Status Relevance. Frontiers in behavioral neuroscience. 2017;11:254 Epub 2018/02/07. 10.3389/fnbeh.2017.00254 ; PubMed Central PMCID: PMCPmc5785725.29403365

Cueva C, Roberts RE, Spencer T, Rani N, Tempest M, Tobler PN, et al Cortisol and testosterone increase financial risk taking and may destabilize markets. Scientific reports. 2015;5:11206 Epub 2015/07/03. 10.1038/srep11206 ; PubMed Central PMCID: PMCPmc4489095.26135946

Jeevanandam S, Muthu PK. 2D:4D Ratio and its Implications in Medicine. Journal of clinical and diagnostic research: JCDR. 2016;10(12):Cm01–cm3. Epub 2017/02/18. 10.7860/JCDR/2016/21952.9000 ; PubMed Central PMCID: PMCPmc5296424.28208851

Wittchen HU, Glaesmer H, Marz W, Stalla G, Lehnert H, Zeiher AM, et al Cardiovascular risk factors in primary care: methods and baseline prevalence rates—the DETECT program. Current medical research and opinion. 2005;21(4):619–30. Epub 2005/05/19. 10.1185/030079905X38187 .15899112

Vautier S, Raufaste E, Cariou M. Dimensionality of the Revised Life Orientation Test and the status of the filler items. International Journal of Psychology. 2003;38:390–400.

Kische H, Pieper L, Venz J, Klotsche J, Marz W, Koch-Gromus U, et al Longitudinal change instead of baseline testosterone predicts depressive symptoms. Psychoneuroendocrinology. 2017;89:7–12. Epub 2018/01/08. 10.1016/j.psyneuen.2017.12.013 .29306775

Galizzi MM, Nieboer J. Digit ratio (2D:4D) and altruism: evidence from a large, multi-ethnic sample. Frontiers in behavioral neuroscience. 2015;9:41 Epub 2015/03/11. 10.3389/fnbeh.2015.00041 ; PubMed Central PMCID: PMCPmc4337370.25755639

Sanchez-Pages S, Turiegano E. Testosterone, facial symmetry and cooperation in the prisoners' dilemma. Physiology & behavior. 2010;99(3):355–61. Epub 2009/12/04. 10.1016/j.physbeh.2009.11.013 .19954750

Bosch-Domenech A, Branas-Garza P, Espin AM. Can exposure to prenatal sex hormones (2D:4D) predict cognitive reflection? Psychoneuroendocrinology. 2014;43:1–10. Epub 2014/04/08. 10.1016/j.psyneuen.2014.01.023 .24703165

Dalton PS, Ghosal S. Self-confidence, Overconfidence and Prenatal Testosterone Exposure: Evidence from the Lab. Frontiers in behavioral neuroscience. 2018;12:5 Epub 2018/02/15. 10.3389/fnbeh.2018.00005 ; PubMed Central PMCID: PMCPmc5797613.29441000

Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, et al Effects of Testosterone Treatment in Older Men. The New England journal of medicine. 2016;374(7):611–24. Epub 2016/02/18. 10.1056/NEJMoa1506119 ; PubMed Central PMCID: PMCPmc5209754.26886521

Gray PB, Singh AB, Woodhouse LJ, Storer TW, Casaburi R, Dzekov J, et al Dose-dependent effects of testosterone on sexual function, mood, and visuospatial cognition in older men. The Journal of clinical endocrinology and metabolism. 2005;90(7):3838–46. Epub 2005/04/14. 10.1210/jc.2005-0247 .15827094

Travison TG, Shackelton R, Araujo AB, Hall SA, Williams RE, Clark RV, et al The natural history of symptomatic androgen deficiency in men: onset, progression, and spontaneous remission. Journal of the American Geriatrics Society. 2008;56(5):831–9. Epub 2008/05/06. 10.1111/j.1532-5415.2008.01679.x ; PubMed Central PMCID: PMCPmc5556701.18454749

Apicella CL, Dreber A, Mollerstrom J. Salivary testosterone change following monetary wins and losses predicts future financial risk-taking. Psychoneuroendocrinology. 2014;39:58–64. Epub 2013/11/28. 10.1016/j.psyneuen.2013.09.025 .24275004

Duke SA, Balzer BW, Steinbeck KS. Testosterone and its effects on human male adolescent mood and behavior: a systematic review. The Journal of adolescent health: official publication of the Society for Adolescent Medicine. 2014;55(3):315–22. Epub 2014/08/26. 10.1016/j.jadohealth.2014.05.007 .25151053

Herzberg PY, Glaesmer H, Hoyer J. Separating optimism and pessimism: a robust psychometric analysis of the revised Life Orientation Test (LOT-R). Psychological assessment. 2006;18(4):433–8. Epub 2006/12/13. 10.1037/1040-3590.18.4.433 .17154764

Puig-Perez S, Hackett RA, Salvador A, Steptoe A. Optimism moderates psychophysiological responses to stress in older people with Type 2 diabetes. Psychophysiology. 2017;54(4):536–43. Epub 2016/12/22. 10.1111/psyp.12806 ; PubMed Central PMCID: PMCPmc5396342.28000236

Snyder CR, Sympson SC, Ybasco FC, Borders TF, Babyak MA, Higgins RL. Development and validation of the State Hope Scale. Journal of personality and social psychology. 1996;70(2):321–35. Epub 1996/02/01. .8636885

[Back]

Fig 1. Optimism and pessimism by baseline testosterone among men.

Linear regression for baseline optimism (green) and pessimism (blue) by baseline total testosterone concentrations. The green and blue lines represent the fitted regression line and the grey areas the 95% confidence intervals.

[Back]

[Back]

Table 1. Sex-specific baseline characteristics of the study population.

Variable | Women (N = 3,840) | Men (N = 2,653) | p-value*
Age, years, | 56.8 (14.6) | 58.4 (13.4) | < 0.01
Total testosterone, ng/ml | 0.41 (0.27; 0.61) | 4.4 (3.3; 5.5) | < 0.01
One-year change in T, ng/ml | -0.13 (-0.23; -0.04) | -0.07 (-0.73; 0.65) | < 0.01
Waist circumference, cm | 90.1 (14.5) | 101.6 (12.5) | < 0.01
Current smoker, % | 19.9 | 22.9 | < 0.01
Physically inactive, % | 34.4 | 27.3 | < 0.01
Sobriety, % | 23.3 | 11.8 | < 0.01
Systolic blood pressure, mmHg | 130 (120, 140) | 130 (120, 145) | < 0.01
Diastolic blood pressure, mmHg | 80 (70; 85) | 80 (75; 85) | < 0.01
LOT-R, total score |  |  |
    Baseline | 15 (13; 18) | 15 (13; 18) | 0.31
    1-year follow-up | 15 (13; 19) | 16 (13; 18) | 0.15
    4-year follow-up | 15 (13; 19) | 16 (13; 19) | 0.66
LOT-R, optimism score |  |  |
    Baseline | 9 (7; 11) | 9 (7; 11) | 0.28
    1-year follow-up | 9 (7; 11) | 9 (7; 11) | 0.19
    4-year follow-up | 9 (7; 11) | 9 (7; 12) | 0.07
LOT-R, pessimism score |  |  |
    Baseline | 5 (3; 7) | 5 (3; 7) | 0.21
    1-year follow-up | 5 (3; 7) | 5 (3; 7) | 0.07
    4-year follow-up | 5 (3; 7) | 5 (3; 7) | 0.40

DOI: 10.1371/journal.pone.0207870.t001

Data are percentages, mean (SD) or median (Q1, Q3).

*Statistical comparisons were performed with χ 2 test (nominal data) or Mann-Whitney-U-test (continuous data). LOT-R, Revised Life-Orientation Test.

[Back]

[Back]

Table 2. Sex-specific associations of total testosterone with optimism, pessimism, and total LOT-R.

| Women | Men | Women | Men
| Cross-sectional | 4-year follow-up
Optimism | β-coefficient
Baseline testosterone | 0.12 (-0.01; 0.25) | 0.008 (-0.05; 0.06) | 0.04 (-0.11; 0.20) | 0.02 (-0.05; 0.09)
Change in testosterone | - | - | -0.03 (-0.19; 0.13) | -0.07 (-0.18; 0.03)
Pessimism |
Baseline testosterone | 0.01 (-0.12; 0.15) | 0.005 (-0.05; 0.06) | 0.05 (-0.08; 0.20) | -0.07 (-0.15; 0.004)
Change in testosterone | - | - | 0.01 (-0.14; 0.18) | -0.02 (-0.13; 0.08)
LOT-R, total score |
Baseline testosterone | 0.11 (-0.07; 0.29) | 0.002 (-0.08; 0.08) | -0.01 (-0.24; 0.22) | 0.08 (-0.03; 0.20)
Change in testosterone | - | - | -0.05 (-0.29; 0.19) | -0.04 (-0.20; 0.11)

DOI: 10.1371/journal.pone.0207870.t002

Data are β-coefficients and their 95% confidence interval in multivariable models, respectively.

Multivariable models were adjusted for age, waist circumference, smoking status, physical inactivity, alcohol consumption, and blood pressure. Longitudinal analyses were additionally weighted for drop-out during follow-up.

LOT-R, Life Orientation Test revised.

[Back]